Sponsor

F-CRIN

Clinical research sponsor

Published trials3

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

3 shown

Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.NCT06754553 · collaborator · 2025-02-01

NOT_YET_RECRUITING

Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.NCT03947216 · collaborator · 2020-10-23

COMPLETED

Soluble Neprilysin, NT-proBNP, and Growth-Differentiation-Factor-15 as Biomarkers for Heart Failure in Dialysis PatientsNCT04061811 · collaborator · 2018-08-01

COMPLETED

Sponsor roles

collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.